US At Cannabis Crossroads: VP Harris Urges DEA Action, Where Do Industry Leaders Stand?
In a bold stance on U.S. cannabis policy, Vice President Kamala Harris is urging the Drug Enforcement Administration (DEA) to accelerate the process of rescheduling marijuana under the Controlled Substances Act.
Speaking at a recent White House meeting with individuals who received pardons for marijuana offenses, Harris criticized the current classification of cannabis, equating it with substances like heroin and deeming it more hazardous than fentanyl. “The classification of cannabis is absurd and patently unfair,” Harris remarked, stressing the urgency for change.
The push for rescheduling comes from the recommendation of the Department of Health and Human Services (HHS) for reclassification.
This move can transform cannabis regulation and enforcement. “I’m sure DEA is working as quickly as possible and will continue to do so,” Harris stated, anticipating the forthcoming adjustments.
Industry Leaders Respond To Rescheduling Proposal
The cannabis industry, represented by figures such as George Archos, CEO of Verano Holdings Corp (OTC:VRNOF), has positively embraced the HHS’s groundbreaking recommendation.
During an in-depth interview with Benzinga, Archos conveyed his enthusiasm for this pivotal shift, articulating the profound impact it could have on the entire market.
‘This rescheduling could mean big things for the entire industry. For HHS to recommend to the DEA to make …